Expression and function of miR-155 in breast cancer

被引:14
|
作者
Liu, Jing [1 ]
Huang, WenHui [1 ]
Yang, HaiXia [2 ]
Luo, Ying [1 ]
机构
[1] Kunming Univ Sci & Technol, Lab Mol Genet Aging & Tumor, Fac Med, Kunming, Yunnan, Peoples R China
[2] Municipal Author Clin Jinan, Outpatient Dept, Jinan, Shandong, Peoples R China
关键词
miR-155; breast cancer; oncogenic miRNA; target genes; TRANSCRIPTION FACTOR FOXO3A; CLINICAL-SIGNIFICANCE; ABERRANT EXPRESSION; CELL-PROLIFERATION; GENE-EXPRESSION; MICRORNAS; GROWTH; METASTASIS; NETWORKS; PATHWAY;
D O I
10.1080/13102818.2015.1043946
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A major problem in the treatment of breast cancer at present is the lack of more sensitive and specific tumour biomarkers. MicroRNAs (miRNAs) were first discovered as important regulators of development in Caenorhabditis elegans, and their functions have been widely investigated. miR-155 is an oncogenic miRNA which has been explored mainly in leukaemia but is also known to play an important role in the progression of breast cancer. There is an accumulating body of evidence about additional roles of miR-155 in the development of breast cancer. In this mini-review, we provide an overview and update of miR-155 expression and its roles in breast cancer. We also attempt to summarize the current understanding of miR-155 regulation networks and speculate on the potential of miR-155 as a putative accessory parameter for diagnosis of breast cancer.
引用
收藏
页码:840 / 843
页数:4
相关论文
共 50 条
  • [21] Diagnostic value of circulating miR-155 for breast cancer: a meta-analysis
    Wang, Fang
    Wang, Jin
    Zhang, Hongjiang
    Fu, Baobao
    Zhang, Yanshun
    Jia, Qianqian
    Wang, Yong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [22] Therapeutic potential of genistein via targeting the microRNA miR-155 in breast cancer
    de la Parra, Columba
    Castillo-Pichardo, Linette
    Cubano, Luis A.
    Calin, George A.
    Dharmawardhane, Suranganie
    MOLECULAR CANCER RESEARCH, 2013, 11
  • [23] Exosome-mediated breast cancer chemoresistance via miR-155 transfer
    Santos, Juliana Carvalho
    Lima, Natalia da Silva
    Sarian, Luis Otavio
    Matheu, Ander
    Ribeiro, Marcelo Lima
    Mauricette Derchain, Sophie Francoise
    SCIENTIFIC REPORTS, 2018, 8
  • [24] Exosome-mediated breast cancer chemoresistance via miR-155 transfer
    Juliana Carvalho Santos
    Natália da Silva Lima
    Luis Otavio Sarian
    Ander Matheu
    Marcelo Lima Ribeiro
    Sophie Françoise Mauricette Derchain
    Scientific Reports, 8
  • [25] miR-155: On the Crosstalk Between Inflammation and Cancer
    Tili, Esmerina
    Croce, Carlo M.
    Michaille, Jean-Jacques
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2009, 28 (05) : 264 - 284
  • [26] Expression profile of miR-148a and miR-155 associated with apoptosis mechanism in pancreatic cancer
    Novais, Paulo C.
    Moscatel, Matheus B.
    Rosa, Marcella S.
    Tirapelli, Daniela
    Cirino, Mucio L.
    Kemp, Rafael
    Santos, Jose S.
    FASEB JOURNAL, 2022, 36
  • [27] Differential Expression Profile of miR-27b, miR-29a, and miR-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients
    Raeisi, Farzaneh
    Mahmoudi, Esmaeil
    Dehghani-Samani, Mina
    Hosseini, Seyedeh Sahar Ebrahimi
    Ghahfarrokhi, Ameneh Mehri
    Arshi, Asghar
    Forghanparast, Kayvan
    Ghazanfari, Samaneh
    MOLECULAR THERAPY-ONCOLYTICS, 2020, 16 : 230 - 237
  • [28] Characterizing the regulation and function of miR-155 in hypoxia biology
    Czochor, Jennifer
    Glazer, Peter M.
    CANCER RESEARCH, 2014, 74 (19)
  • [29] Altered miR-155 Expression in Allergic Asthmatic Airways
    Malmhall, C.
    Johansson, K.
    Winkler, C.
    Alawieh, S.
    Ekerljung, L.
    Radinger, M.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 85 (04) : 300 - 307
  • [30] miR-155 expression in antitumor immunity: The higher the better?
    Michaille, Jean-Jacques
    Awad, Hamdy
    Fortman, Emily C.
    Efanov, Alexander A.
    Tili, Esmerina
    GENES CHROMOSOMES & CANCER, 2019, 58 (04): : 208 - 218